145 related articles for article (PubMed ID: 32935600)
1. Clinical characteristics of thrombospondin type-1 domain-containing 7A-associated membranous nephropathy.
Suzuki T; Han W; Watanabe S; Terashita M; Nakata M; Ichikawa D; Shirai S; Shibagaki Y
Ren Fail; 2020 Nov; 42(1):966-968. PubMed ID: 32935600
[No Abstract] [Full Text] [Related]
2. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.
Gödel M; Grahammer F; Huber TB
N Engl J Med; 2015 Mar; 372(11):1073. PubMed ID: 25760365
[No Abstract] [Full Text] [Related]
3. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.
Meyer-Schwesinger C; Lambeau G; Stahl RA
N Engl J Med; 2015 Mar; 372(11):1074-5. PubMed ID: 25760364
[No Abstract] [Full Text] [Related]
4. Glomerular disease: thrombospondin type-1 domain-containing 7A-a new player in membranous nephropathy.
Allison SJ
Nat Rev Nephrol; 2015 Feb; 11(2):63. PubMed ID: 25447129
[No Abstract] [Full Text] [Related]
5. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.
Tomas NM; Beck LH; Meyer-Schwesinger C; Seitz-Polski B; Ma H; Zahner G; Dolla G; Hoxha E; Helmchen U; Dabert-Gay AS; Debayle D; Merchant M; Klein J; Salant DJ; Stahl RAK; Lambeau G
N Engl J Med; 2014 Dec; 371(24):2277-2287. PubMed ID: 25394321
[TBL] [Abstract][Full Text] [Related]
6. Multi-Autoantibody Signature and Clinical Outcome in Membranous Nephropathy.
Ghiggeri GM; Seitz-Polski B; Justino J; Zaghrini C; Payré C; Brglez V; Dolla G; Sinico A; Scolari F; Vaglio A; Prunotto M; Candiano G; Radice A; Bruschi M; Lambeau G;
Clin J Am Soc Nephrol; 2020 Dec; 15(12):1762-1776. PubMed ID: 33257410
[TBL] [Abstract][Full Text] [Related]
7. Characterization of autoantibodies in primary membranous nephropathy and their clinical significance.
Stahl RA; Reinhard L; Hoxha E
Expert Rev Clin Immunol; 2019 Feb; 15(2):165-175. PubMed ID: 30433832
[No Abstract] [Full Text] [Related]
8. Clinical and Histological Features of Phospholipase A2 Receptor-Associated and Thrombospondin Type-I Domain-containing 7A-Associated Idiopathic Membranous Nephropathy: A Single Center Retrospective Study from China.
Zhang D; Zou J; Zhang C; Zhang W; Lin F; Jiang G
Med Sci Monit; 2018 Jul; 24():5076-5083. PubMed ID: 30032157
[TBL] [Abstract][Full Text] [Related]
9. A Novel Insight into the Role of PLA2R and THSD7A in Membranous Nephropathy.
Zhang P; Huang W; Zheng Q; Tang J; Dong Z; Jiang Y; Liu Y; Liu W
J Immunol Res; 2021; 2021():8163298. PubMed ID: 34337081
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy.
Tomas NM; Hoxha E; Reinicke AT; Fester L; Helmchen U; Gerth J; Bachmann F; Budde K; Koch-Nolte F; Zahner G; Rune G; Lambeau G; Meyer-Schwesinger C; Stahl RA
J Clin Invest; 2016 Jul; 126(7):2519-32. PubMed ID: 27214550
[TBL] [Abstract][Full Text] [Related]
11. [Membranous glomerulonephritis : An example of individualized medicine in nephrology].
Stahl RAK; Hoxha E
Internist (Berl); 2019 May; 60(5):440-449. PubMed ID: 30859275
[TBL] [Abstract][Full Text] [Related]
12. Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy.
Zaghrini C; Seitz-Polski B; Justino J; Dolla G; Payré C; Jourde-Chiche N; Van de Logt AE; Booth C; Rigby E; Lonnbro-Widgren J; Nystrom J; Mariat C; Cui Z; Wetzels JFM; Ghiggeri G; Beck LH; Ronco P; Debiec H; Lambeau G
Kidney Int; 2019 Mar; 95(3):666-679. PubMed ID: 30784662
[TBL] [Abstract][Full Text] [Related]
13. The Prevalence, Characteristics, and Putative Mechanisms of Dual Antigen-Positive Membranous Nephropathy: The Underestimated Condition.
Uchida T; Oda T
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892120
[TBL] [Abstract][Full Text] [Related]
14. Management of Membranous Nephropathy in the PLA
Bomback AS
Clin J Am Soc Nephrol; 2018 May; 13(5):784-786. PubMed ID: 29378770
[No Abstract] [Full Text] [Related]
15. Antigen-Specific IgG Subclasses in Primary and Malignancy-Associated Membranous Nephropathy.
von Haxthausen F; Reinhard L; Pinnschmidt HO; Rink M; Soave A; Hoxha E; Stahl RAK
Front Immunol; 2018; 9():3035. PubMed ID: 30619370
[TBL] [Abstract][Full Text] [Related]
16. An Indirect Immunofluorescence Method Facilitates Detection of Thrombospondin Type 1 Domain-Containing 7A-Specific Antibodies in Membranous Nephropathy.
Hoxha E; Beck LH; Wiech T; Tomas NM; Probst C; Mindorf S; Meyer-Schwesinger C; Zahner G; Stahl PR; Schöpper R; Panzer U; Harendza S; Helmchen U; Salant DJ; Stahl RA
J Am Soc Nephrol; 2017 Feb; 28(2):520-531. PubMed ID: 27436855
[TBL] [Abstract][Full Text] [Related]
17. Combined Plasmatic and Tissue Approach to Membranous Nephropathy-Proposal of a Diagnostic Algorithm Including Immunogold Labelling: Changing the Paradigm of a Serum-based Approach.
L'Imperio V; Pieruzzi FG; Sinico RA; Nebuloni M; Tosoni A; Granata A; Santoro D; Capelli I; Garozzo M; Casano S; Smith A; Radice A; Pagni F
Appl Immunohistochem Mol Morphol; 2020; 28(5):376-383. PubMed ID: 30925495
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous remission of proteinuria is a frequent event in phospholipase A2 receptor antibody-negative patients with membranous nephropathy.
Hoxha E; Harendza S; Pinnschmidt HO; Tomas NM; Helmchen U; Panzer U; Stahl RA
Nephrol Dial Transplant; 2015 Nov; 30(11):1862-9. PubMed ID: 26142398
[TBL] [Abstract][Full Text] [Related]
19. Factor H Autoantibodies and Membranous Nephropathy.
Seikrit C; Ronco P; Debiec H
N Engl J Med; 2018 Dec; 379(25):2479-2481. PubMed ID: 30575481
[No Abstract] [Full Text] [Related]
20. Translational Aspects of Primary Membranous Nephropathy.
Hoxha E; Stahl RAK
Semin Nephrol; 2017 Sep; 37(5):436-446. PubMed ID: 28863791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
